Hydrap-ES
Hydrap-ES Brand names, Hydrap-ES Analogs
- Cam-Ap-Es
- Demi-Regroton
- Diupres-250
- Diupres-500
- Diutensen-R
- Dralserp
- Hiserpia
- Hydrap-ES
- Hydromox R
- Hydroserpine Plus (R-H-H)
- Metatensin #2
- Metatensin #4
- Naquival
- Novoreserpine
- Rau-Sed
- Regroton
- Renese-R
- Reserfia
- Salutensin
- Salutensin-Demi
- Sandril
- Ser-A-Gen
- Serpalan
- Serpalan (TN)
- Serpanray
- Serpasil
- Serpasil-Apresoline
- Serpasil-Esidrix #1
- Serpasil-Esidrix #2
- Serpate
- Serpivite
- Unipres
Hydrap-ES Brand Names Mixture
- Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
- Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
- SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)
Hydrap-ES Chemical_Formula
C33H40N2O9
Hydrap-ES RX_link
No information avaliable
Hydrap-ES fda sheet
Hydrap-ES msds (material safety sheet)
Hydrap-ES Synthesis Reference
No information avaliable
Hydrap-ES Molecular Weight
608.679 g/mol
Hydrap-ES Melting Point
264.5 oC
Hydrap-ES H2O Solubility
73 mg/L
Hydrap-ES State
Solid
Hydrap-ES LogP
3.32
Hydrap-ES Dosage Forms
Tablets
Hydrap-ES Indication
Foe the treatment of hypertension
Hydrap-ES Pharmacology
Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.
Hydrap-ES Absorption
No information avaliable
Hydrap-ES side effects and Toxicity
Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg
Hydrap-ES Patient Information
No information avaliable
Hydrap-ES Organisms Affected
Humans and other mammals
